Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| CATALANA OCCIDENTE | - | 4 | +0,41 % | ||
| EBRO FOODS | - | 3 | +0,23 % | ||
| VIDRALA | - | 3 | -0,32 % | ||
| CIE AUTOMOTIVE | - | 3 | +0,77 % | ||
| PHARMAMAR | - | 2 | -0,64 % | ||
| GRENERGY RENOVABLES | - | 2 | +0,98 % | ||
| TUBACEX | - | 1 | 0,00 % | ||
| ALMIRALL | - | 1 | -0,57 % | ||
| CAF | - | 1 | +1,33 % | ||
| ELECNOR | - | 1 | +1,06 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | EDREAMS ODIGEO, S.A.: The Company informs of the transactions carried out over its own shares under the Buy-back Program. | 2 | CNMV | ||
| Do | HBX GROUP INTERNATIONAL PLC: The Company informs about the execution of a capital reduction by virtue of the reallocation of share premium account to distributable reserves | 14 | CNMV | ||
| Do | Absci Corporation: Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target | 146 | GlobeNewswire (Europe) | Almirall selects second target in AI Drug Creation collaborationExpanded collaboration builds on Absci's successful de novo molecule design for difficult-to-drug targets in the first stage of the... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .